Scinai Immunotherapeutics Ltd. SCNI
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.52$0.57
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 12/31/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | 22.27% | 6.43% | -10.98% | ||
| Total Depreciation and Amortization | 66.01% | -28.16% | -28.83% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -164.85% | 8.06% | -21.02% | ||
| Change in Net Operating Assets | -315.87% | -140.95% | 231.02% | ||
| Cash from Operations | -60.63% | -60.59% | 12.74% | ||
| Capital Expenditure | -3,633.33% | -- | 50.00% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -3,633.33% | -- | 50.00% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | 3.07% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 56.74% | 4.73% | 12,208.33% | ||
| Foreign Exchange rate Adjustments | -- | -1,125.00% | 134.71% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -1,350.00% | -63.28% | 98.97% | ||